Covered recipient · General Payments record
JOHN BENJAMIN JESS AREVALO
Allopathic & Osteopathic Physicians Pain Medicine Interventional Pain Medicine
General Payments · PY2023–2024
$4,391.49
- Reported across 36 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $1,199.15 | 6 |
| Food and Beverage | $775.20 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| BOSTON SCIENTIFIC CORPORATION | $891.96 | 3 |
| MML US, Inc. | $674.17 | 7 |
| Abbott Laboratories | $306.13 | 4 |
| SI-BONE, INC. | $52.13 | 1 |
| TerSera Therapeutics LLC | $29.73 | 1 |
| Medtronic, Inc. | $20.23 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $85.45 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125162342 | CMS |
| Abbott Laboratories | $111.09 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125162344 | CMS |
| Abbott Laboratories | $81.80 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125162346 | CMS |
| Abbott Laboratories | $27.79 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125162348 | CMS |
| Boston Scientific Corporation | $195.38 | 04/05/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1092241486 | CMS |
| Boston Scientific Corporation | $646.21 | 04/05/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1092241488 | CMS |
| Boston Scientific Corporation | $50.37 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092241644 | CMS |
| Medtronic, Inc. | $20.23 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119410176 | CMS |
| MML US, Inc. | $93.72 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152306179 | CMS |
| MML US, Inc. | $153.10 | 11/15/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1152306181 | CMS |
| MML US, Inc. | $30.00 | 11/15/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1152306183 | CMS |
| MML US, Inc. | $153.47 | 11/15/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1152306185 | CMS |
| MML US, Inc. | $201.42 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152306187 | CMS |
| MML US, Inc. | $20.99 | 11/18/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1152306189 | CMS |
| MML US, Inc. | $21.47 | 11/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152306191 | CMS |
| SI-BONE, INC. | $52.13 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120068807 | CMS |
| TerSera Therapeutics LLC | $29.73 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144715821 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.